文献速递骨质疏松与代谢性骨病创伤骨科

BMD对髋部及其他骨折的预测价值:用于更新FRAX的荟萃分析

Predictive value of BMD for hip and other fractures: a meta-analysis to update FRAX.
PubMed 文献 · Osteoporos Int · 2026-03-12

该荟萃分析汇总53项队列研究、307205名男性和女性的原始数据,评估股骨颈DXA测量的骨密度(BMD)与骨折风险的关系。低BMD是骨折风险的重要预测因素,尤其对髋部骨折;风险梯度随年龄增长而降低,但主要骨质疏松性骨折(MOF)的风险梯度不随年龄变化。结论支持股骨颈BMD用于病例发现策略,并需考虑年龄、性别、随访时间和BMD值对预测价值的影响。

要点

  • 股骨颈BMD可强烈预测髋部骨折,男女风险梯度相似。
  • 髋部骨折风险梯度随年龄增长而降低,MOF风险梯度不随年龄变化。
  • 多数髋部骨折发生于基线低骨量或骨质疏松者。

核心结论

  • 股骨颈BMD是骨折风险的重要预测因素,尤其对未来髋部骨折。
  • 年龄较大时关联强度较低,提示非骨骼因素参与髋部骨折风险。
  • 国际验证支持其用于病例发现策略,但需考虑年龄、性别、随访时间和BMD值的影响。

研究设计与样本

  • 研究纳入53项以人群为基础的队列,共307205名男性和女性,平均随访8.7年,总计2683185人年。
  • 按性别在各队列中使用泊松模型分析BMD与骨折风险的关联,结果以风险梯度(GR,每降低1个标准差BMD的风险比)表示。
  • 不同研究通过加权系数合并。

主要发现

  • 多数髋部骨折发生于基线低骨量或骨质疏松的男性和女性(分别为73%和92%),MOF分别为65%和85%。
  • 股骨颈BMD强烈预测髋部骨折,男女在任何给定T值下的风险梯度和绝对风险相似。
  • 65岁时髋部骨折GR男性为2.73(95% CI 2.29-3.26),女性为2.61(95% CI 2.34-2.92)。
  • 50岁时髋部骨折GR男性为3.49(95% CI 2.51-4.84),80岁时降至2.14(1.96-2.34);女性分别为3.23(2.75-3.80)和2.11(1.99-2.44)。
  • MOF的GR不随年龄变化(女性p=0.12,男性p=0.89);髋部骨折GR随随访时间延长显著降低,但效应幅度较年龄影响小。

关键数值与推荐

  • 股骨颈BMD每降低1个标准差,髋部骨折风险梯度在65岁男性为2.73(95% CI 2.29-3.26),女性为2.61(95% CI 2.34-2.92)。
  • 50岁男性髋部骨折GR为3.49(95% CI 2.51-4.84),80岁降至2.14(1.96-2.34)。
  • 50岁女性髋部骨折GR为3.23(2.75-3.80),80岁降至2.11(1.99-2.44)。
  • MOF的GR不随年龄变化(女性p=0.12,男性p=0.89)。

临床怎么用

  • 股骨颈BMD可用于骨折风险评估和病例发现策略。
  • 解读BMD预测价值时需考虑年龄、性别、随访时间和BMD值。
  • 更新FRAX时应纳入BMD预测价值随年龄等变化的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: The relationship between bone mineral density (BMD) at the femoral neck and fracture risk was determined in a meta-analysis of primary data of 307205 men and women from 53 cohort studies. Low BMD was an important predictor of fracture risk, particularly for hip fracture. INTRODUCTION: This study aimed to quantify the relationship between DXA-measured femoral neck BMD and fracture risk and examine the effect of age, sex, time since measurement, and initial BMD value on fracture risk, with a view to updating FRAX®. METHODS: We studied 307,205 men and women from within 53 predominately population-based cohorts followed up for an average of 8.7 years and a total of 2,683,185 person-years. The association of BMD and fracture risk was examined using a Poisson model in each cohort separately by sex. Results were expressed as a gradient of risk (GR, hazard ratio/standard deviation decrease in BMD). The different studies were then merged using weighted coefficients. RESULTS: Most hip fractures arose in men and women with low bone mass or osteoporosis at baseline (73% and 92%, respectively) as was also the case for MOF (65% and 85%, respectively). BMD at the femoral neck strongly predicted hip fractures both in men and women with a similar gradient of risk and absolute risk at any given T-score. At the age of 65 years, the GR was 2.73 (95% CI = 2.29-3.26) in men and 2.61 (95% CI = 2.34-2.92) in women. However, the magnitude of association was significantly dependent on age, with a higher gradient of risk at younger ages. For example, at age 50 years, the GR was 3.49 (95% CI 2.51-4.84) in men and decreased to 2.14 (1.96-2.34) at age 80 years. The change in GR with age was slightly less marked in women (3.23 [2.75-3.80] and 2.11 [1.99-2.44], respectively). The GR for major osteoporotic fracture (MOF) remained unchanged with age (p = 0.12 for women and p = 0.89 for men). A significant decrease in GR for hip fracture was observed with increasing duration of follow-up, but the magnitude of the effect was modest compared with the effect of age. For other fracture outcomes, including non-hip major osteoporotic fracture, the gradient of risk was lower than for hip fracture. CONCLUSIONS: Femoral neck BMD is a risk factor for fracture of substantial importance, particularly for future hip fracture. The lower magnitude of association at older age is consistent with other non-skeletal factors contributing to hip fracture risk with advancing age. Its validation on an international basis supports its use in case finding strategies. Its use should, however, take account of the variations in predictive value of BMD with age, sex, length of follow-up, and BMD.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Kanis JA, McCloskey EV, Johansson H, et al. Predictive value of BMD for hip and other fractures: a meta-analysis to update FRAX. Osteoporos Int. 2026. PMID: 41820630. doi:10.1007/s00198-026-07925-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。